Schnapp P
Department of Geriatric Medicine, District General Hospital, Bratislava, Czechoslovakia.
Int J Clin Pharmacol Ther Toxicol. 1989 Sep;27(9):442-4.
Following a two-week placebo period a group of 10 elderly men (63-76 years) received a 20 mg nifedipine tablet each. Twelve hours later nifedipine, as compared to placebo, significantly raised diuresis, urine sodium excretion, and tubular sodium rejection, but had no effect on GFR and urine potassium excretion. A significant decrease in mean arterial BP was registered in the 6th hour following nifedipine. In spite of persisting natriuresis, the statistical significance of the antihypertensive effect dropped tenfold in the 12th hour; moreover, correlation analysis did not show any relationship between natriuresis and BP drop. Although the mechanism of the natriuretic effect of Ca2+ channel blockers is not yet fully understood, it seems that the increase in Na+ excretion might be due to inhibition of Na+ reabsorption in renal tubules. It appears, though, that, following a single dose of nifedipine, the changes in Na+ excretion did not immediately contribute to the BP decrease.
在为期两周的安慰剂期之后,一组10名老年男性(63 - 76岁)每人服用一片20毫克的硝苯地平片。12小时后,与安慰剂相比,硝苯地平显著增加了尿量、尿钠排泄和肾小管钠排泄,但对肾小球滤过率和尿钾排泄没有影响。硝苯地平服用后第6小时,平均动脉血压显著下降。尽管持续存在利钠作用,但在第12小时,降压效果的统计学显著性下降了10倍;此外,相关性分析未显示利钠作用与血压下降之间存在任何关系。虽然钙通道阻滞剂的利钠作用机制尚未完全阐明,但似乎钠排泄的增加可能是由于肾小管中钠重吸收受到抑制。然而,似乎在单次服用硝苯地平后,钠排泄的变化并未立即导致血压下降。